207 related articles for article (PubMed ID: 9266734)
1. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
[TBL] [Abstract][Full Text] [Related]
2. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
[TBL] [Abstract][Full Text] [Related]
3. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A
Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204
[TBL] [Abstract][Full Text] [Related]
4. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues.
Menchine M; Emelin JK; Mischel PS; Haag TA; Norman MG; Pepkowitz SH; Welsh CT; Townsend JJ; Vinters HV
Mod Pathol; 1996 Nov; 9(11):1071-80. PubMed ID: 8933518
[TBL] [Abstract][Full Text] [Related]
5. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
Geist RT; Reddy AJ; Zhang J; Gutmann DH
Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918
[TBL] [Abstract][Full Text] [Related]
7. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
8. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas.
Platten M; Meyer-Puttlitz B; Blümcke I; Waha A; Wolf HK; Nöthen MM; Louis DN; Sampson JR; von Deimling A
J Neuropathol Exp Neurol; 1997 Jul; 56(7):806-10. PubMed ID: 9210877
[TBL] [Abstract][Full Text] [Related]
9. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
Marsh J; Mukherjee P; Seyfried TN
Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
[TBL] [Abstract][Full Text] [Related]
10. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
[TBL] [Abstract][Full Text] [Related]
11. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.
Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE
Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
13. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
[TBL] [Abstract][Full Text] [Related]
14. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
15. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
16. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.
Parry L; Maynard JH; Patel A; Hodges AK; von Deimling A; Sampson JR; Cheadle JP
Hum Genet; 2000 Oct; 107(4):350-6. PubMed ID: 11129334
[TBL] [Abstract][Full Text] [Related]
18. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Ess KC; Kamp CA; Tu BP; Gutmann DH
Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.
Jozwiak J; Kotulska K; Grajkowska W; Jozwiak S; Zalewski W; Oldak M; Lojek M; Rainko K; Maksym R; Lazarczyk M; Skopinski P; Wlodarski P
Brain Dev; 2007 Jun; 29(5):273-80. PubMed ID: 17071037
[TBL] [Abstract][Full Text] [Related]
20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
